Pharmaceutical Investing Cytokinetics and Astellas Provide Updates Regarding Collaborative Skeletal Muscle Program
Pharmaceutical Investing Approval of Linzess Tablets 0.25 mg in Japan for Additional Indication of Chronic Constipation
